Sunday, July 27, 2025
HomeTagsHealthcare

Healthcare

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that the Italian Medicines Agency, or Agenzia Italiana del...

Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central

Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a...

Novavax COVID-19 Vaccine Nuvaxovid Recommended for Expanded Conditional Marketing Authorization

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has...

Meltmedia joins Evoke, Boosting Data-Driven Omnichannel and Marketing Technology Capabilities

Meltmedia, an award-winning provider of digital strategy, design, and development services to the life science industry, has been acquired by Evoke, a global brand,...

RegeneRx Licensee to Expand Phase 3 Clinical Trial Program with RGN-259

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics